{"schema_version":"secwatch.filing_event.v1","accession":"0001428336-23-000028","form_type":"8-K","ticker":"HQY","cik":"0001428336","company_name":"HEALTHEQUITY, INC.","filed_at":"2023-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.897779+00:00","generated_at":"2026-06-13T13:11:25.303334+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"HealthEquity CFO Tyson Murdock to depart after Aug 2023 10-Q filing; receives $100k retention bonus","bullets":["CFO Tyson Murdock will cease as CFO following filing of Q2 FY2024 10-Q, expected in early September 2023.","Murdock receives a $100,000 retention bonus for staying through filing date and assisting with 10-Q.","After filing, Murdock may serve as Special Advisor to CEO until November 30, 2023, for transition.","Termination is without cause; Murdock eligible for previously negotiated severance benefits.","No successor CFO named; a new CFO will be appointed after transition period."],"urls":{"canonical":"https://secwatch.observer/filing/0001428336-23-000028","json":"https://secwatch.observer/filing/0001428336-23-000028.json","markdown":"https://secwatch.observer/filing/0001428336-23-000028.md","text":"https://secwatch.observer/filing/0001428336-23-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1428336/000142833623000028/0001428336-23-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1428336/000142833623000028/hqy-20230630.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T13:11:25.303334+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f6d21b715a","claim":"Tyson Murdock departed as Chief Financial Officer at HEALTHEQUITY, INC..","evidence_excerpt":"Tyson Murdock will cease serving as Chief Financial Officer following the filing of the Company’s Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission (the “SEC”) for the fiscal quarter ending July 31, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1428336/000142833623000028/0001428336-23-000028-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will cease serving as"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}